2Xideas US Inc

Stealth Alerts is a cutting-edge technology company based in New York, NY that specializes in providing advanced security solutions for businesses and individuals. With a focus on discretion and efficiency, Stealth Alerts offers a range of customizable alert systems and monitoring services to help clients protect their assets and maintain peace of mind. Generated from their business information

Oppenheimer & Co. Inc.'s flagship branch at 666 Third Avenue in New York is a hub for approximately 100 Financial Professionals. With over 30 years of history in the community, this office manages assets exceeding $20 billion for both domestic and international private clients and institutional relationships. The branch offers a wide range of financial services, including guidance on corporate cash management, futures, corporate stock options, and other executive services, fostering a culture of collaboration and innovation. Affiliated with Oppenheimer Asset Management Inc. and the Investment Banking department, the office emphasizes ongoing interactions to provide clients with a competitive edge. The branch's commitment to excellence is exemplified by the recent recognition of two of its advisors, Christopher Lazos and David Schoenkin, on the 2022 Forbes|SHOOK Best-In-State Wealth Advisors List. This achievement underscores Oppenheimer & Co. Inc.'s dedication to delivering top-tier financial advisory services to its clientele. Generated from the website content

Ramius LLC is an investment management company based in New York, NY, offering differentiated strategies to a diverse client base of sophisticated investors. They aim to meet the dynamic needs of their clients, which include institutions, corporations, pension plans, sovereign wealth funds, foundations and endowments, multi-family offices, and high net worth individuals. With a focus on delivering value, Ramius LLC invests in deeply undervalued companies and actively engages with management teams and boards of directors to unlock opportunities for the benefit of all shareholders. They also specialize in royalty acquisition in the biopharmaceutical sector, providing innovative solutions to commercial or near-commercial stage products.Generated from the website